From Agios to Deciphera, Steve Hoerter plots another oncology launch; Roche exec Christiane Hamachar moves to India as CEO of Biocon Biologics

? Deciphera $DCPH has scooped Agios? chief commercial officer Steve Hoerter to fill retiring CEO Michael Taylor?s shoes. The Waltham, MA-based biotech is placing its trust in Hoerter?s sales acumen, especially for cancer drugs, acquired throughout his career at companies like Clovis, Roche, Genentech, Chiron, and Eli Lilly. The first